Dannielle Appelhans
Director/Board Member at GENERATION BIO CO.
Net worth: 63 600 $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cameron McDonough | M | 53 | 7 years | |
| Jason Rhodes | M | 54 | 8 years | |
| John J. Puisis | M | - |
Cour Pharmaceuticals Development Co., Inc.
 Cour Pharmaceuticals Development Co., Inc. BiotechnologyHealth Technology Cour Pharmaceuticals Development Co., Inc. engages in the development of therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. Its product pipeline include celiac disease, peanut allergy, multiple sclerosis, and neutralizing antibodies. The company was founded by John J. Puisis and Jim Herrmann and is headquartered in Chicago, IL. | - |
| Jeff Jonas | M | 71 | 6 years | |
| Yalonda Howze | F | 52 | 1 years | |
| Gustav Christensen | M | 76 | 7 years | |
| Charles Rowland | M | 65 | 6 years | |
| Robert Carey | M | 65 |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. BiotechnologyHealth Technology Cour Pharmaceuticals Development Co., Inc. engages in the development of therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. Its product pipeline include celiac disease, peanut allergy, multiple sclerosis, and neutralizing antibodies. The company was founded by John J. Puisis and Jim Herrmann and is headquartered in Chicago, IL. | 1 years |
| Anthony Quinn | M | 62 | 7 years | |
| Matthew Norkunas | M | 46 | 4 years | |
| Donald Nicholson | M | 67 | 7 years | |
| Antoinette Paone | F | 46 | 6 years | |
| Ronald Cooper | M | 61 | 3 years | |
| Catherine Stehman-Breen | M | 61 | 7 years | |
| Maren Killackey | F | - | - | |
| Phillip Samayoa | M | 37 | 6 years | |
| Matthew Stanton | M | 51 | 7 years | |
| James Jogerst | M | - | 3 years | |
| Carlos Montoya | M | - |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. BiotechnologyHealth Technology Cour Pharmaceuticals Development Co., Inc. engages in the development of therapies designed to reprogram the immune system to achieve antigen-specific tolerance for immune-mediated disease. Its product pipeline include celiac disease, peanut allergy, multiple sclerosis, and neutralizing antibodies. The company was founded by John J. Puisis and Jim Herrmann and is headquartered in Chicago, IL. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Noubar Afeyan | M | 61 | 9 years | |
| Francis Cuss | M | 70 | 5 years | |
| Anne Prener | M | 66 | 3 years | |
| Petra Kaufmann | M | 58 | 3 years | |
| Sara Den Besten | F | - | - | |
| Spencer Fisk | M | - | 4 years | |
| Maiken Keson-Brookes | F | 52 | 3 years | |
| Catherine Sohn | M | 71 | 5 years | |
| Jose Carmona | M | 51 | 2 years | |
| Natalie Holles | F | 51 | 3 years | |
| David Epstein | M | 62 | 5 years | |
| Joanne M. Protano | F | 55 | 5 years | |
| Jonathan Symonds | M | 66 | 5 years | |
| Douglas Kerr | M | 57 | 5 years | |
| Michael Rosenblatt | M | 76 | 9 years | |
| Susanne Antonie Schaffert | M | 57 | 1 years | |
| Bryan Gillis | M | - | 4 years | |
| Robert May | M | 56 | 2 years | |
| Tracy Zimmermann | M | 54 | 4 years | |
| Theo Proukou | M | - | 5 years | |
| Greg Whitehead | M | - | 3 years | |
| Laurence Turka | M | 66 | 3 years | |
| David Lennon | M | 53 | 1 years | |
| Mark Hernon | M | - | 1 years | |
| Christina Coughlin | M | 54 | 1 years | |
| Sean Gaskell | M | 42 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 45 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dannielle Appelhans
- Personal Network
